Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 802.00 | 736.00 | 1.0897 | 1.1482 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 634.00 | 736.00 | 0.8614 | 0.7664 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 625.00 | 320.09 | 879.00 | 736.00 | 1.1943 | 1.3186 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 320.09 | 910.00 | 736.00 | 1.2364 | 1.3865 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 917.00 | 736.00 | 1.2459 | 1.4017 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 625.00 | 320.09 | 323.00 | 736.00 | 0.4389 | 0.0076 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 1068.00 | 736.00 | 1.4511 | 1.7267 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 924.00 | 736.00 | 1.2554 | 1.4170 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 942.00 | 736.00 | 1.2799 | 1.4561 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 625.00 | 320.09 | 1051.00 | 736.00 | 1.4280 | 1.6905 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 805.00 | 736.00 | 1.0938 | 1.1549 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 930.00 | 736.00 | 1.2636 | 1.4300 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 713.00 | 736.00 | 0.9688 | 0.9478 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 320.09 | 931.00 | 736.00 | 1.2649 | 1.4322 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 560.00 | 736.00 | 0.7609 | 0.5930 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 320.09 | 271.00 | 736.00 | 0.3682 | -0.1294 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 681.00 | 736.00 | 0.9253 | 0.8748 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 644.00 | 736.00 | 0.8750 | 0.7896 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 625.00 | 320.09 | 788.00 | 736.00 | 1.0707 | 1.1170 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 648.00 | 736.00 | 0.8804 | 0.7988 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 940.00 | 736.00 | 1.2772 | 1.4518 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 398.00 | 736.00 | 0.5408 | 0.1988 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 824.00 | 736.00 | 1.1196 | 1.1972 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 444.00 | 736.00 | 0.6033 | 0.3131 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 681.00 | 736.00 | 0.9253 | 0.8748 |